Abstract
Cytochrome c (Cyt c) has been implicated as a serum marker for aberrant apoptosis and, thus, has considerable clinical potential. Using a sandwich enzyme-linked immunosorbent assay (ELISA) we found that the sensitivity of Cyt c detection is reduced in the presence of serum. The inhibitory factor responsible was purified from both fetal bovine serum and human serum employing standard chromatography procedures followed by affinity chromatography on Affi-Gel 10-bound Cyt c. In SDS-PAGE, bands at 44 kD and 50 kD were observed for the bovine and human proteins, respectively. Mass spectrometry analysis identified the serum inhibitory factor as leucine-rich alpha-2-glycoprotein-1 (LRα2GP1). This identification may lead to a modified ELISA to quantify total Cyt c in patients’ sera. LRα2GP1 is the first extracellular ligand for Cyt c that has been identified. A physiological function associated with binding is suggested.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- BLAST:
-
basic local alignment search tool
- BSA:
-
bovine serum albumin
- Cyt c :
-
cytochrome c
- DEAE:
-
diethylaminoethyl
- ELISA:
-
enzyme-linked immunosorbent assay
- HRP:
-
horseradish peroxidase
- mAbs:
-
monoclonal antibodies
- LRα2GP1:
-
leucine-rich alpha-2-glycoprotein-1
- MALDI-TOF MS:
-
matrix assisted laser desorption ionization time-of-flight mass spectrometry
- PBS:
-
phosphate-buffered saline
- SDS-PAGE:
-
polyacrylamide gel electrophoresis in sodium dodecylsulfate
References
Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112:481–490
Jemmerson R, Dubinsky JM, Brustovetsky N (2005) Cytochrome c release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. Antiox Redox Signal 7:1158–1172
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157
Zou H, Henzel WJ, Liu X, et al (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405–413
Li P, Nijhawan D, Budihardjo I, et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489
Boehning D, Patterson RL, Sedaghat L, et al (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5:1051–1061
Nur-E-Kamal A, Gross SR, Pan Z, Balklava Z, et al (2004) Nuclear translocation of cytochrome c during apoptosis. J Biol Chem 279:24911–24914
Kagan VE, Borisenko GG, Tyurina YY, et al (2004) Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Rad Biol Med 37:1963–1985
Jemmerson R, Laplante B, Treeful A (2002) Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. Cell Death Differ. 9:538–548
Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M (2001) Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 98:1542–1548
Pullerits R, Bokarewa M Jonsson I-M, et al (2005) Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology 44:32–39
Barczyk K, Kreuter M, Pryjma J, et al (2005) Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 116:167–173
Gvatua NA, Komissarenko SV, Skok MV, et al (1990) Determination of the concentration of cytochrome c and its antibodies in the blood serum for the diagnosis and prognosis of complications in myocardial infarct patients. Ter Arkh 62:58–61
Alleyne T, Joseph J, Sampson V (2001) Cytochrome c detection: a diagnostic marker for myocardial infarction. Appl Biochem Biotech 90:97–105
Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, et al. (2003) Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J Intern Med 254:168–175
Adachi N, Hirota M, Hamaguchi M, Okamoto K, et al (2004) Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 342:127136-
Nunoi H, Mercado MR, Mizukami T, et al (2005) Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int 47:175–179
Engvall E (1980) Enzyme immunoassay ELISA and EMIT. Meth Enzymol 70:419–439
Urbanski GJ, Margoliash E (1976) The antigenicity of cytochrome c. In: M. Salton, (ed). The immunochemistry of enzymes and their antibodies: J. Wiley and Sons New York pp. 203–226
Goshorn SC, Retzel E, Jemmerson R (1991) Common structural features among monoclonal antibodies binding the same antigenic region of cytochromes. J Biol Chem 266:2134–2142
Minnerath JM, Crump BL, Margoliash E, Jemmerson R (1995) Major and minor epitopes on the self antigen mouse cytochrome c mapped by site-directed mutagenesis. Mol Immunol 32:795–803
Urbanski GJ Margoliash E (1977) Topographic determinants on cytochrome c. I. The complete antigenic structures of rabbit, mouse, and guanaco cytochromes c in rabbits and mice. J Immunol 118:1170–1180
Glatz JF, Veerkamp JH (1983) Removal of fatty acids from serum albumin by Lipidex 1000 chromatography. J Biochem Biophys Methods 8:57–61
Cotter R (1996) Time-of-flight mass spectrometry: Instrumentation and applications in biological research, American Chemical Society
Carlson SS, Mross GA, Wilson AC, et al (1977) Primary structure of mouse, rat, and guinea pig cytochrome c. Biochemistry 16:1437–1442
Brown JR (1975) Structure of bovine serum albumin. Fed Proc 34:591–591
O’Donnell LC, Druhan LJ, Avalos BR (2002) Molecular characterization and expression analysis of leucine-rich α2 glycoprotein, a novel marker of granulocytic differentiation. J Leuk Biol 72:478–485
Takahashi N, Takahashi Y, Putnam FW (1985) Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich α2-glycoprotein of human serum. Proc Natl Acad Sci USA 82:1906–1910
Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition motif. Curr Op Struct Biol 11:725–732
Sanishvili R, Volz KW, Westbrook EM, Margoliash E (1995) The low ionic strength crystal structure of horse cytochomre c at 2.1 Å resolution and comparison with its high ionic strength counterpart. Structure 3:707–716
Spector AA (1975) Fatty acid binding to plasma albumin. J Lipid Res 16:165–179
Tuominen EKJ, Wallace CJA, Kinnunen, PKJ (2002) Phospholipid-cytochrome c interaction. Evidence for the extended lipid anchorage. J Biol Chem 277:8822–8826.
Jemmerson R, Liu J, Hausauer D, Lam K-P, et al. (1999) conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipids vesicles. Biochem 38:3599–3609
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by: NIH NINDS 5R21-NS45589
Rights and permissions
About this article
Cite this article
Cummings, C., Walder, J., Treeful, A. et al. Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay. Apoptosis 11, 1121–1129 (2006). https://doi.org/10.1007/s10495-006-8159-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-006-8159-3